The American Heart Association (AHA) has issued an updated scientific statement on the detection, evaluation, and management of resistant hypertension (RH). Areas covered in the updated statement for diagnosing RH include identifying and correcting medication non-adherence, analyzing whether blood pressures (BPs) have been taken correctly, understanding the white coat effect, and if there is suboptimal antihypertensive therapy being recommended. Among the highlights:
- Lifestyle factors such as obesity, dietary sodium, alcohol consumption, physical inactivity, and dietary pattern are all linked to RH.
- Several classes of pharmacologic agents can increase BP and contribute to drug-induced RH, including NSAIDs, oral contraceptives and hormone replacement therapy, and immunosuppressive agents.
- Evaluation of RH should start with a thorough medical history, physical examination, collection in out-of-office BP monitoring, laboratory evaluation, and non-invasive imaging if warranted.
- Management of RH incorporates lifestyle interventions and adding exercise to the management regimen. It also includes pharmacological treatment and referral to a hypertension specialist if warranted.
Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: Detection, evaluation, and management. A scientific statement from the American Heart Association. [Published online ahead of print September 13, 2018]. Hypertension. doi:10.1161/HYP.0000000000000084.
This Week's Must Reads
Acellular Pertussis Vaccine Is Safe & Effective, JAMA Pediatr; 2018 Nov; Wood, Nolan, et al
Influenza and Pertussis Vaccination in Pregnancy, Vaccine; ePub 2018 Nov 3; Wilcox, Bottrell, et al
Influenza Vaccine Efficacy in High-Risk Patients, Vaccine; ePub 2018 Nov 9; Shang, Chung, et al
Childhood Vaccination Coverage Rates Compared, J Paediatr Child Health; ePub 2018 Nov 13; Baumann, et al
Measles Immunity After Vaccination in Children with HIV, Clin Infect Dis; ePub 2018 Nov 12; Mutsaerts, et al
Must Reads in Cardiology
CVD Events Prevented with New AHA BP Guideline, Circulation; ePub 2018 Nov 19; Bress, et al
PUFAs for Primary & Secondary CVD Prevention, Cochrane Library; ePub 2018 Nov 27; Abdelhamid, et al
Is Obesity Associated With Adverse CV Outcomes?, JAMA Netw Open; 2018 Nov 16; Riaz, et al
Cholesterol Guidelines Stress Lifetime Approach, Circulation; ePub 2018 Nov 10; Grundy, et al
Does Vitamin D Reduce Cancer & CVD Risk?, N Engl J Med; ePub 2018 Nov 10; Manson, et al